The treatment of liver fibrosis induced by hepatocyte growth factor-directed, ultrasound-targeted microbubble destruction in rats

Clinical Imaging

Volumn 33, Issue 6, 2009, Pages 454-461

  Wang, Zhao Xia ^a   Wang, Zhi Gang ^a   Ran, Hai Tao ^a   Ren, Jian Li ^a   Zhang, Yong ^a   Li, Qiao ^a   Zhu, Ye Feng ^a   Ao, Meng ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Gene delivery; Hepatocyte growth factor; Microbubbles

Indexed keywords

COLLAGEN I; DIFFUSION WEIGHTED IMAGING; GENE DELIVERY; GENE THERAPY; HEPATOCYTE GROWTH FACTOR; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; MICROBUBBLES; NOVEL STRATEGIES; ULTRASOUND-TARGETED MICROBUBBLE DESTRUCTION; WESTERN BLOTTING; WISTAR RAT;

ACOUSTIC WAVES; BIOACTIVITY; COLLAGEN; GENE TRANSFER; PEPTIDES; RATS; ULTRASONIC APPLICATIONS; ULTRASONIC IMAGING; ULTRASONICS;

LIVER;

COLLAGEN TYPE 1; SCATTER FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DISEASE MODEL; GENE THERAPY; GENETIC TRANSFECTION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; MALE; MICROBUBBLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TREATMENT OUTCOME; ULTRASOUND THERAPY; WESTERN BLOTTING;

ANIMALS; GENE THERAPY; HEPATOCYTE GROWTH FACTOR; LIVER CIRRHOSIS; MALE; MICROBUBBLES; RATS; RATS, WISTAR; SONICATION; TRANSFECTION; TREATMENT OUTCOME;

EID: 70350173934     PISSN: 08997071     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinimag.2009.07.001     Document Type: Article

References (28)

1. Friedman S.L. Liver fibrosis-from bench to bedside. J Hepatol 38 Suppl 1 (2003) S38-S53
2. Bataller R., and Brenner D.A. Liver fibrosis. J Clin Invest 115 (2005) 209-218
3. Isner J.M. Myocardial gene therapy. Nature 415 (2002) 234-239
4. Yla-Herttuala S., and Martin J.F. Cardiovascular gene therapy. Lancet 355 (2000) 213-222
5. Nishino M., Iimuro Y., Ueki T., et al. Hepatocyte growth factor improves survival after partial hepatectomy in cirrhotic rats suppressing apoptosis of hepatocytes. J Surg 144 3 (2008) 374-384
6. Ozawa S., Uchiyama K., Nakamori M., et al. Combination gene therapy of HGF and truncated type II TGF-beta receptor for rat liver cirrhosis after partial hepatectomy. Surgery 139 4 (2006) 563-573
7. Li F., Sun J.Y., Wang J.Y., et al. Effect of hepatocyte growth factor encapsulated in targeted liposomes on liver cirrhosis. J Control Release 131 1 (2008) 77-82
8. Taniyama Y., Tachibana K., Hiraoka K., et al. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther 9 (2002) 372-380
9. Matsumoto K., and Nakamura T. Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun 239 (1997) 639-644
10. Liu Y. Hepatocyte growth factor and the kidney. Curr Opin Nephrol Hypertens 11 (2002) 23-30
11. Matsumoto K., and Nakamura T. Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney Int 59 (2001) 2023-2038
12. Michalopoulos G.K., and DeFrances M.C. Liver regeneration. Science 276 (1997) 60-66
13. Vargas G.A., Hoeflich A., and Jehle P.M. Hepatocyte growth factor in renal failure: promise and reality. Kidney Int 57 (2000) 1426-1436
14. Eddy A.A. Molecular basis of renal fibrosis. Pediatr Nephrol 15 (2000) 290-301
15. Klahr S., and Morrissey J. Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 283 (2002) F861-F875
16. Wang Z., Wang Z., Xu C., et al. Experimental study on preparation of lipid ultrasound microbubbles loaded gene and polylysine. Chinese J Ultrasound Med 25 2 (2009) 101-104
17. Abedi-Valugerdi M., Aghdami N., Khorram Khorshid H.R., et al. Evaluation of long-term effects of herbal drug formulation IMOD™ in laboratory animals. Iran J Allergy Asthma Immunol 6 Suppl 6 (2007) S9
18. Taouli B., Vilgrain V., Dumont E., et al. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesion with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology 226 (2003) 71-78
19. Kanemura H., Iimuro Y., Takeuchi M., et al. Hepatocyte growth factor gene transfer with naked plasmid DNA ameliorates dimethylnitrosamine-induced liver fibrosis in rats. J Hepatol Res 38 9 (2008) 930-939
20. Kiyama S., Yamada T., and Iwata H. Reduction of fibrosis in a rat model of non-alcoholic steatohepatitis cirrhosis by human HGF gene transfection using electroporation. J Gastroenterol Hepatol 23 8 Pt 2 (2008) 471-476
21. Hellgren I., Gorman J., and Sylven C. Factors controlling the efficiency of Tat-mediated plasmid DNA transfer. J Drug Target 12 (2004) 39-47
22. Grenier N. Diffusion-weighted MR imaging of the abdomen: a new clinical tool?. J Radiol 85 3 (2004) 301-306
23. Boulanger Y., Amara M., Lepanto L., et al. Diffusion-weighted MR imaging of the liver of hepatitis C patients. NMR Biomed 16 3 (2003 May) 132-136
24. Khvorostinka V.M., Il'chenko I.A., and Bobronnikova L.R. Variations of treatment of chronic alcohol diffusion liver disease. Lik Sprava 3 (2001) 154-155
25. Friedman S.L. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275 (2000) 2247-2250
26. Nieto N., Friedman S.L., and Cederbaum A.I. Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species. Hepatology 35 (2002) 62-73
27. Zhigang W., Zhiyu L., Haitao R., et al. Ultrasound-mediated microbubble destruction enhances VEGF gene delivery to the infarcted myocardium in rats. Clin Imaging 28 (2004) 395-398
28. Price R., Skyba D., Kaul S., and Skalak T. Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. Circulation 98 (1998) 1264-1267